Loading clinical trials...
Loading clinical trials...
Prevention of NEphronic PErt in People With Type 2 DIABETIC Disease Followed in General Practice
This work will make it possible to identify the nephron loss of type 2 diabetic patients in the western region and to better define in general practice the impact of the elements put in place to reduce this loss and to raise awareness of the importance of these measures through training in comparison with a control group.
Age
50 - No limit years
Sex
ALL
Healthy Volunteers
No
Start Date
July 1, 2026
Primary Completion Date
May 1, 2027
Completion Date
July 1, 2027
Last Updated
December 26, 2025
360
ESTIMATED participants
training and audit
OTHER
Routine care
OTHER
Lead Sponsor
University Hospital, Lille
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions